Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.25M P/E - EPS this Y - Ern Qtrly Grth -
Income -1.92M Forward P/E - EPS next Y - 50D Avg Chg 27.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -36.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -84.00%
Recommedations - Quick Ratio 0.06 Shares Outstanding 172.20M 52W Low Chg 124.00%
Insider Own 48.26% ROA -854.35% Shares Float 85.57M Beta -3.27
Inst Own 0.62% ROE - Shares Shorted/Prior -/- Price 0.07
Gross Margin - Profit Margin - Avg. Volume 305,399 Target Price -
Oper. Margin - Earnings Date Nov 7 Volume 87,000 Change 0.00%
About NASCENT BIOTECH INC

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.

NBIO Chatroom

User Image Hogtrader08 Posted - 3 days ago

$NBIO LETS GOOOOOOOOOOOOO

User Image ok2buy Posted - 1 week ago

$NBIO OTCN sitting cheapest ask at $0.055, the next cheapest is $0.067. Cheaper by 0.0102 then the next closest. Doesn't sound like much, but it is. About as greasy as it comes./

User Image ok2buy Posted - 1 week ago

$NBIO As usual, OTCN sitting cheapest ask. They are there a lot of the time, dumping cheap shares./

User Image ok2buy Posted - 1 week ago

$NBIO Sorry, I misspoke. Company has actually been around longer. Makes me feel even worse./

User Image ok2buy Posted - 1 week ago

$NBIO Company coming up 10 years in February 2025. Look at a max chart. Guaranteed it will make you cry!

User Image ok2buy Posted - 1 week ago

$NBIO Wait for tax loss season. Getting close now. Pick up 100,000 or 200,000 shares for a penny or two. Would be looking at anywhere between $1-4 k for a large amount of shares. I believe it is coming. I hope I am wrong. For those who might question, the 52 week low is $0.0303. Enough said for me./

User Image ok2buy Posted - 1 week ago

$NBIO These guys just want to keep milking the cow. Get a nice salary and stock options on the cheap. Does anyone want to roll up their sleeves and actually do some work here?/

User Image J1983 Posted - 1 week ago

$NBIO has the real deal in PTB. There’s no question with the data over the last 20 years. Sean, you need to sell, get this moving,or get out of the way and let someone else take over.

User Image ok2buy Posted - 1 week ago

$NBIO For what it is worth, had a large bid in at 4 cents sitting on the system. Cancelled today. I no longer want shares at 4 cents, I want them at 1-2 cents. That is a problem. Management, are you paying attention! And no more weak a$$ excuses either about the stock's performance. Share holders have heard enough!/

User Image ok2buy Posted - 1 week ago

$NBIO J1983. Totally agree. Management needs to be fired. Neither one deserves the $100+K they get in salary from the company. I will be looking as we approach December for anything in the 1-2 cent range. There is at least one large share holder in particular and at last check, he owned millions of shares. If he decides he has had enough, it could start a massive sell off as he exits. I hope that doesn't happen, but one never knows. Best of luck to the faithful longs. Btw, I had hoped I was wrong today, but back down to $0.04's. Shameful!

User Image J1983 Posted - 1 week ago

$NBIO Nothing. Ever. We bag holders just sit and wait as this thing drops to nothing.

User Image ok2buy Posted - 1 week ago

$NBIO Looks like this dirty dog is setting up to trade $0.04's today. Cheaper than my buy. Management.....anything??

User Image ok2buy Posted - 1 week ago

$NBIO Small buy actually happened this morning for me. Testing the waters. I am shocked! 5000 shares at $0.0551/share.

User Image ok2buy Posted - 1 week ago

$NBIO As suspected, sat at the top of the bid all afternoon. Nobody sold me a single share on a small 5000 share order. If you wanted shares in the afternoon, you had to hit the ask. What about the 22,700 shares that someone dumped into the bid this morning from 11:26-11:28 hrs., at $0.0544/share. So greasy here. Almost maddening! I still think these shares trade inter brokerage house designed to cause others to start selling and dump some new shares into the bid. Get a selling wave going. Guys, start putting bids in the 5 - 6 cent range. I can't be the only one. We need to start cleaning this garbage up! Best of luck to the faithful longs. Not these slimy scroats./

User Image ok2buy Posted - 1 week ago

$NBIO Every time this greasy $hit is happening here, I am going to put in bids. This has got to stop!

User Image J1983 Posted - 1 week ago

$NBIO ok2buy You are right that it’s cross trades between these aholes. Nothing will happen until Sean gets it through his head he needs to sell at a reasonable 50-80 million and let PTB pass to a big pharma that can get it through FDA and to cancer patients.

User Image ok2buy Posted - 1 week ago

$NBIO Put my bid in, someone quickly increases the bid and jumps over me. Good luck getting cheap shares. I think these are being dolled out as cross trades between the same brokerage house or between a few "friends". So greasy here!

User Image ok2buy Posted - 1 week ago

$NBIO Enough of this. Let's see if I can actually buy some today. My bet is that these are all greasy cross trades. My bids are in. Whoever is playing games here, why don't you go F@ch yourself!

User Image ok2buy Posted - 1 week ago

$NBIO This is what infuriates me! The stock hits $0.0875/share and then gets sold down to $0.0541. That is total bull$hit!

User Image ok2buy Posted - 1 week ago

$NBIO Someone continually grabbing cheap shares in the 5-6 cent range. Repeated low volume accumulation on the cheap to amass a position. Would be nice if sellers here started to yank their asks, we might actually see the shares go up in price.

User Image J1983 Posted - 1 week ago

$NBIO 💨

User Image ok2buy Posted - 2 weeks ago

$NBIO I would hope they are looking for a buyer or at a minimum, a pharma to partner with. Perhaps they still believe that developing the drug is within their scope of expertise?? I do know one thing, I have been here too long waiting for good things to happen./

User Image J1983 Posted - 2 weeks ago

$NBIO Yup. Come on, Sean. Find a buyer.

User Image ok2buy Posted - 2 weeks ago

$NBIO 100 shares sold, drops the price by 29 %+. So dirty here.

User Image ok2buy Posted - 3 weeks ago

$NBIO If those nickel shares purchased today got held and not penny flipped, then perhaps someone is accumulating in anticipation of a bigger run. Oh, dare to dream. Best of luck to the faithful longs, the good DR., the lovely Miss Katie, SL, BP and MG./

User Image ok2buy Posted - 3 weeks ago

$NBIO Please put up some more nickel shares on the ask. I can play as well. I will take them all!

User Image ok2buy Posted - 3 weeks ago

$NBIO So greasy. Are these cross trades to bring the price down? Or did someone just give their friend some cheap ones? Have not felt the love here in a long time./

User Image J1983 Posted - 3 weeks ago

$NBIO and here comes a drop back down to a nickel. F you, CDEL.

User Image boda2019 Posted - 10/30/24

$NBIO https://pubmed.ncbi.nlm.nih.gov/38012357/ Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance PMID: 38012357 DOI: 10.1007/s10555-023-10154-7 Abstract This comprehensive review explores vimentin as a pivotal therapeutic target in cancer treatment, with a primary focus on mitigating metastasis and overcoming drug resistance. Vimentin, a key player in cancer progression, is intricately involved in processes such as epithelial-to-mesenchymal transition (EMT) and resistance mechanisms to standard cancer therapies. The review delves into diverse vimentin inhibition strategies. ....It underscores the growing recognition of vimentin as a pivotal therapeutic target in cancer and presents a diverse array of inhibitors, including antibodies, nanobodies, DNA and RNA aptamers, vaccines, and miRNAs. These multifaceted approaches hold substantial promise for tackling metastasis and overcoming drug resistance, collectively presenting new avenues for enhanced cancer therapy.

User Image Laylos Posted - 10/25/24

$NBIO looking like someone testing low volume and O/S here with the buys and sells. If you get some more low volume accumulation and if new twits start showing up and could be a group set to run this...

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
HOLDEN LOWELL THOMAS CFO CFO Jan 27 Buy 0.14 20,000 2,800 8,418,277 02/02/23
HOLDEN LOWELL THOMAS CFO CFO Jul 21 Sell 0.26 5,000 1,300 8,112,277 07/25/22